[Skip to Navigation]
Sign In
Comment & Response
August 2018

Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer

Author Affiliations
  • 1Division of Urology, University of Toronto, Toronto, Ontario, Canada
  • 2Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
JAMA Oncol. 2018;4(8):1133. doi:10.1001/jamaoncol.2018.0748

To the Editor The article by Patel et al1 emphasizes the limitations of active surveillance in an intermediate-risk cohort of men with prostate cancer. It is particularly disappointing that there were no predictive features that allowed a prediction of favorable risk on final pathologic analysis in the low-volume Gleason 3 + 4 (grade group [GG] 2) cohort.

Add or change institution